Innovative Genomics Initiative

The campus announced G. Steven Martin, campus professor emeritus of cell and developmental biology, as its new interim vice chancellor for research in an email from Chancellor Carol Christ sent to the campus community Thursday afternoon. His appointment will be effective Monday.

Thanks to CRISPR-Cas9 gene editing, which can manipulate the human genome, sickle cell disease is one step closer to a cure.

UC Berkeley researchers have developed an improved method for gene-editing in mice that will allow for more efficient and accessible genetic modeling.

UC Berkeley, partnering with UC San Francisco and the pharmaceutical industry, launched on Wednesday an initiative to research and develop gene-editing technologies for future medical care.